Skip to main content
SpringerLink
Log in

Cutaneous melanoma—The benefit of screening and preventive measures

  • short review
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Summary

The incidence rates of cutaneous melanoma are continually rising in the Caucasian population with the highest rates in Australia and New Zealand. The genesis of melanoma is a complex interplay between genetic predisposition and exogenous factors. The major known exogenous risk factor of this potentially lethal malignancy is ultraviolet (UV) radiation. In the last decades diverse prevention strategies have been developed which in case of primary prevention are aimed to protect the skin from high-dose UV radiation. Although its effect is only visible after a long period of time and despite the growing awareness in the general population, it seems that primary prevention interventions are often not carried out as recommended. It was proposed that particularly in Europe where incidence rates are still increasing, the development and implementation of primary prevention campaigns should be pursued further. Secondary prevention implies early detection of melanoma by using skin cancer screenings. However, according to recent reviews there is only limited evidence on impact and benefit of routine skin cancer screenings in the adult general population. Thus, it was suggested that future research should focus on effects of targeted screening in population subgroups with increased risk for melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol. 2001;14(5):280–90.

    Article  CAS  PubMed  Google Scholar 

  2. International Agency for Research on Cancer WHO. GLOBOCAN 2018: Estimated age-standardized incidence rates in 2018, melanoma of skin, both sexes, all ages. 2019. http://globocan.iarc.fr. Accessed 29 Jan 2019.

    Google Scholar 

  3. Erdmann F, Lortet-Tieulent J, Schüz J, et al. International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? Int J Cancer. 2013;132(2):385–400.

    Article  CAS  PubMed  Google Scholar 

  4. Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene. 2003;22(20):3099–112.

    Article  CAS  PubMed  Google Scholar 

  5. MacKie RM. Incidence, risk factors and prevention of melanoma. Eur J Cancer. 1998;34(Suppl 3):3–6.

    Article  Google Scholar 

  6. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41(1):45–60.

    Article  PubMed  Google Scholar 

  7. Pleasance ED, Cheetham RK, Stephens PJ, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 2010;463(7278):191–6.

    Article  CAS  PubMed  Google Scholar 

  8. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340(17):1341–8.

    Article  CAS  PubMed  Google Scholar 

  9. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control. 2001;12(1):69–82.

    Article  CAS  PubMed  Google Scholar 

  10. Ghiasvand R, Rueegg CS, Weiderpass E, Green AC, Lund E, Veierød MB. Indoor tanning and melanoma risk: long-term evidence from a prospective population-based cohort study. Am J Epidemiol. 2017;185(3):147–56.

    PubMed  Google Scholar 

  11. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41(1):28–44.

    Article  PubMed  Google Scholar 

  12. van der Leest RJ, Flohil SC, Arends LR, de Vries E, Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2015;29(6):1053–62.

    Article  PubMed  Google Scholar 

  13. Ford D, Bliss JM, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer. 1995;62(4):377–81.

    Article  CAS  PubMed  Google Scholar 

  14. Ransohoff KJ, Jaju PD, Tang JY. Familial skin cancer syndromes: increased melanoma risk. J Am Acad Dermatol. 2016;74(3):423–34.

    Article  PubMed  Google Scholar 

  15. Marks R. Campaigning for melanoma prevention: a model for a health education program. J Eur Acad Dermatol Venereol. 2004;18(1):44–7.

    Article  PubMed  Google Scholar 

  16. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Curiel-Lewandrowski C, Chen SC, Swetter SM. Screening and prevention measures for melanoma: is there a survival advantage? Curr Oncol Rep. 2012;14(5):458–67.

    Article  PubMed  PubMed Central  Google Scholar 

  18. World Health Organization. World Health Organization. https://www.who.int/uv/intersunprogramme/activities/uv_index/en/. Accessed 1 March 2019.

  19. S3 Leitlinie Prävention von Hautkrebs, Version 1.1, 2014

  20. Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol. 2011;29(3):257–63.

    Article  CAS  PubMed  Google Scholar 

  21. Montague M, Borland R, Sinclair C. Slip! Slop! Slap! and SunSmart, 1980–2000: Skin cancer control and 20 years of population-based campaigning. Health Educ Behav. 2001;28(3):290–305.

    Article  CAS  PubMed  Google Scholar 

  22. van der Leest RJ, de Vries E, Bulliard JL, et al. The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010. J Eur Acad Dermatol Venereol. 2011;25(12):1455–65.

    Article  PubMed  Google Scholar 

  23. https://sonneohnereue.at/2019/05/12/aktuelle-termine-2019/. Accessed 1 June 2019.

  24. Swindler JE, Lloyd JR, Gil KM. Can sun protection knowledge change behavior in a resistant population? Cutis. 2007;79(6):463–70.

    PubMed  Google Scholar 

  25. Seité S, Del Marmol V, Moyal D, Friedman AJ. Public primary and secondary skin cancer prevention, perceptions and knowledge: an international cross-sectional survey. J Eur Acad Dermatol Venereol. 2017;31(5):815–20.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Falk M, Magnusson H. Sun protection advice mediated by the general practitioner: an effective way to achieve long-term change of behaviour and attitudes related to sun exposure? Scand J Prim Health Care. 2011;29(3):135–43.

    Article  PubMed  PubMed Central  Google Scholar 

  27. McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol. 2006;54(5):783–92.

    Article  PubMed  Google Scholar 

  28. Terushkin V, Halpern AC. Melanoma early detection. Hematol Oncol Clin North Am. 2009;23(3):481–500.

    Article  PubMed  Google Scholar 

  29. Breitbart EW, Waldmann A, Nolte S, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012;66(2):201–11.

    Article  PubMed  Google Scholar 

  30. Choudhury K, Volkmer B, Greinert R, Christophers E, Breitbart EW. Effectiveness of skin cancer screening programmes. Br J Dermatol. 2012;167(Suppl 2):94–8.

    Article  PubMed  Google Scholar 

  31. Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: a systematic review. J Am Acad Dermatol. 2017;76(1):129–139.e10.

    Article  PubMed  Google Scholar 

  32. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for skin cancer: US preventive services task force recommendation statement. JAMA. 2016;316(4):429–35.

    Article  Google Scholar 

  33. Katalinic A, Eisemann N, Waldmann A. Skin cancer screening in Germany. Documenting melanoma incidence and mortality from 2008 to 2013. Dtsch Arztebl Int. 2015;112(38):629–34.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria

    Magdalena Seidl-Philipp MD & Van Anh Nguyen MD

Authors
  1. Magdalena Seidl-Philipp MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Van Anh Nguyen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Magdalena Seidl-Philipp MD.

Ethics declarations

Conflict of interest

M. Seidl-Philipp and V.A. Nguyen declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seidl-Philipp, M., Nguyen, V.A. Cutaneous melanoma—The benefit of screening and preventive measures. memo 12, 235–238 (2019). https://doi.org/10.1007/s12254-019-0512-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-019-0512-7

Keywords

Search

Navigation